PubMed HealthSearch

Biomedical subjects

P Thuvasethakul

Publications and source records attributed to P Thuvasethakul.

9 recordsLinked to original sources

Urinary vanilmandelic acid determination using column chromatography.

A simple method for determination of urinary vanilmandelic acid, VMA, using column chromatography was described. The interfering substances in the urine were eliminated by passing the urine through a Dowex-1 x 2, 50-100 mesh, column and washing the column with distilled water. The VMA was eluted from the resin using K2CO3-containing 3.0 mol/l NaCl solution and determined spectrophotometrically after periodate oxidation reaction. This method yielded a standard curve which was linear up to 50 mg/l. The recoveries of the method as determined by addition technique ranged from 92.1 to 100.4 per cent with an average of 97.3 per cent. The method yielded satisfactory precisions with the coefficients of variation (C.V.) of less than 5.50 and 6.95 per cent for within-run and between-run experiments respectively. The method was sensitive to the concentrations of 1.2 mg/l with recovery of 92.5 per cent and 2.6 mg/l with the recovery of 109.9 per cent for the standard and urinary VMA respectively. No interfering effects were found from epinephrine and norepinephrine (up to 2,000 micrograms/l), acetylsalicylic acid (up to 50 mg/l) and homovanillic acid (up to 10 mg/l) added to the pooled urine. The correlation coefficients (r) of 0.909 (n = 100) and 0.905 (n = 100) were obtained when the urinary VMA values determined by the proposed and Pisano's methods and expressed as mg/l and mg/g creatinine were compared respectively. The column could be reused at least 5 times. The technique is suitable for any routine clinical laboratory.

Chromatography

Urinary neopterin in patients with systemic lupus erythematosus.

Concentrations of neopterin were measured in urine specimens from 35 patients with active and eight with inactive systemic lupus erythematosus (SLE). Compared with those of apparently healthy controls, neopterin concentrations were higher in patients with active disease (P less than 0.001) and with inactive disease (P less than 0.01), those in patients with active disease being significantly higher than those in patients with inactive disease (P less than 0.001). The correlation between the neopterin concentration and evidence of disease activity was good. All of the patients with clinically active SLE had increased neopterin, but for only 37.5% (three of eight) did the neopterin concentration exceed the upper normal limit during clinical remission. The increase in neopterin concentration did not correlate with clinical courses or severity of renal function. Moreover, serial determinations of neopterin in active SLE patients showed a rapid decrease of initially high concentration, paralleling a decline of clinical activity after initiation of medical therapy. Thus, urinary neopterin may be a useful marker for monitoring disease activity in SLE patients.

Adolescent

Prospective study on premature labor with magnesium sulfate.

The efficacy of magnesium sulfate was evaluated as the primary tocolytic agent in the management of patients at risk for premature delivery. Fifteen patients presenting with premature labor between 28 and 35 weeks gestation, given titrated dose intravenously magnesium sulfate till uterine contraction ceased, were prospectively studied. All patients received an additional oral beta-mimetic agent once labor was arrested till 36 weeks gestation. All cases had intact membranes and no contraindications for tocolytic therapy. Tocolysis for more than 72 hours was achieved in 14 cases (93.3%). Delayed tocolysis of more than 7 days was achieved in 13 cases (86.7%). The mean dosage to achieve tocolytic effect was 3.17 g/hr (SD 0.08). The mean serum magnesium level to achieve such effect was 5.38 mg/dl (SD 0.88). Magnesium sulfate was found to be easy to administer and clinically efficacious with minimal adverse effects. It may be used as the first line of tocolytic therapy where beta-sympathomimetic drugs are contraindicated.

Adult

Human pancreatic alpha-amylase. II. Effects of pH, substrate and ions on the activity of the enzyme.

Purified human pancreatic alpha-amylase (alpha-1,4-glucan 4-glucano-hydrolase, EC 3.2.1.1) was found to be stable over a wide range of pH values (5.0 to 10.5) with an optimal pH for the enzymatic activity of 7.0. The Michaelis constant of the enzyme at optimal pH and assay conditions was found to be 2.51 mg per ml for soluble starch. Halide ions were required for the activity of the enzyme whereas sulfate and nitrate were not. The order of effectiveness of activation was found to be: Cl- greater than Br- greater than I- greater than F-. Calcium and magnesium were activators at concentrations of 0.001M and 0.005M, respectively, but exhibited inhibitory effects at concentrations higher than 0.005M. At 0.01M ethylenediamine tetraacetic acid (EDTA) concentration the enzymatic activity upon seven min incubation, was inhibited up to 96%. The inhibition of EDTA and calcium could be reversed upon addition of calcium and EDTA, respectively.

Amylases

Human pancreatic alpha-amylase. I. Purification and characterization.

alpha-Amylase was extracted from human pancreas and purified by using ammonium sulfate fractionation, Sephadex G-100 and DEAE-Sephadex A-50 column chromatography. The enzyme was shown to be homogenous by three different criteria: polyacrylamide disc gel electrophoresis, SDS polyacrylamide gel electrophoresis and analytical ultracentrifugation. The values of SO20,w, D20,w, v, and frictional ration of the enzyme were calculated to be 5.01S, 7.56D, 0.718 ml g-1 and 1.10, respectively. The molecular weight of the alpha-amylase was determined by three different methods: sedimentation velocity-diffusion, conventional sedimentation equilibrium and SDS polyacrylamide gel electrophoresis and was found to be 57,850; 50,100 and 53,200 g mole-1, respectively (average value 53,700). The amino acid composition of the enzyme was determined and compared with those of alpha-amylases from various other sources.

Amino Acids